Showing 661-680 of 8668 for: Cochrane Systematic Reviews Back
- Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
Cochrane Systematic Reviews, 30-Aug-2013
Rebleeding is an important cause of death and disability in people with aneurysmal subarachnoid haemorrhage. Rebleeding is probably related to dissolution of the blood clot at the site of aneurysm rupture by natural fibrinolytic activity. This review is a
- Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions
Cochrane Systematic Reviews, 19-Apr-2019
Minor oral surgery or dental extractions (oral or dental procedures) are widely performed and can be complicated by hazardous oral bleeding, especially in people with an inherited bleeding disorder such as haemophilia or Von Willebrand disease (VWD). The
- Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
Cochrane Systematic Reviews, 2-Jul-2018
Individuals on continuous treatment with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs) are at increased risk of bleeding complications during and after oral or dental procedures. Anticoagulant treatment is preferably continued at the
- Antifibrinolytic therapy to reduce haemoptysis from any cause
Cochrane Systematic Reviews, 2-Nov-2016
Haemoptysis is a common pathology around the world, occurring with more frequency in low-income countries. It has different etiologies, many of which have infectious characteristics. Antifibrinolytic agents are commonly used to manage bleeding from differ
- Anti‐fibrinolytic use for minimising perioperative allogeneic blood transfusion
Cochrane Systematic Reviews, 16-Mar-2011
Concerns regarding the safety of transfused blood have led to the development of a range of interventions to minimise blood loss during major surgery. Anti-fibrinolytic drugs are widely used, particularly in cardiac surgery, and previous reviews have foun
- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Cochrane Systematic Reviews, 15-Mar-2016
People with haematological disorders are frequently at risk of severe or life-threatening bleeding as a result of thrombocytopenia (reduced platelet count). This is despite the routine use of prophylactic platelet transfusions to prevent bleeding once the
- Antifibrinolytics for heavy menstrual bleeding
Cochrane Systematic Reviews, 15-Apr-2018
Heavy menstrual bleeding (HMB) is an important physical and social problem for women. Oral treatment for HMB includes antifibrinolytic drugs, which are designed to reduce bleeding by inhibiting clot-dissolving enzymes in the endometrium.
- Antifungal agents for preventing fungal infections in non‐neutropenic critically ill patients
Cochrane Systematic Reviews, 16-Jan-2016
Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi
- Antifungal agents for preventing fungal infections in solid organ transplant recipients
Cochrane Systematic Reviews, 12-May-2009
Invasive fungal infections (IFIs) are important causes of morbidity and mortality in solid organ transplant recipients.
- Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
Cochrane Systematic Reviews, 8-Nov-2016
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung functio
- Antifungal therapy for newborn infants with invasive fungal infection
Cochrane Systematic Reviews, 13-Jun-2012
A variety of antifungal drugs, drug preparations and drug combinations are available to treat newborn infants with suspected or confirmed invasive fungal infection. There is a need to assess their relative merits.
- Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections
Cochrane Systematic Reviews, 17-Feb-2010
Invasive fungal infections are associated with significant morbidity and mortality in children. Optimal treatment strategies are yet to be defined.
- Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated with autologous haematopoietic stem cell transplantation
Cochrane Systematic Reviews, 24-Apr-2019
Neuroblastoma is a rare malignant disease that primarily affects children. The tumours mainly develop in the adrenal medullary tissue, and an abdominal mass is the most common presentation. High-risk disease is characterised by metastasis and other primar
- Antigen‐specific active immunotherapy for ovarian cancer
Cochrane Systematic Reviews, 10-Sep-2018
This is the second update of the review first published in the Cochrane Library (2010, Issue 2) and later updated (2014, Issue 9).
- Antiglucocorticoid and related treatments for psychosis
Cochrane Systematic Reviews, 16-Dec-2015
Hypothalamic-pituitary-adrenal (HPA) axis dysregulation has been implicated in the development and relapse of psychotic disorders. Elevated cortisol secretion has been positively linked with symptom severity in people with psychosis. Antiglucocorticoid an
- Antiglucocorticoid treatments for mood disorders
Cochrane Systematic Reviews, 4-Dec-2015
Antiglucocorticoids may have antidepressant effects and have been reported to be efficacious in the treatment of severe psychiatric disorders. The efficacy and safety of antiglucocorticoid treatments for mood disorders is the subject of this systematic re
- Antihelminthics in helminth‐endemic areas: effects on HIV disease progression
Cochrane Systematic Reviews, 14-Apr-2016
Helminth infections, such as soil-transmitted helminths, schistosomiasis, onchocerciasis, and lymphatic filariasis, are prevalent in many countries where human immunodeficiency virus (HIV) infection is also common. There is some evidence from observationa
- Antihistamines and/or decongestants for otitis media with effusion (OME) in children
Cochrane Systematic Reviews, 7-Sep-2011
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 4, 2006.
- Anti-histamines for prolonged non-specific cough in children
Cochrane Systematic Reviews, 19-Nov-2009
Non-specific cough is defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology. It is commonly seen in paediatric practice. These children are treated with a variety of therapies including anti-histamines. Also
- Antihistamines for the common cold
Cochrane Systematic Reviews, 23-Nov-2015
The common cold is an upper respiratory tract infection, most commonly caused by a rhinovirus. It affects people of all age groups and although in most cases it is self limiting, the common cold still causes significant morbidity. Antihistamines are commo
